GAME-OvBLOC: Drug Wastage : Observational Study in the Operating Rooms of France

Sponsor
Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05609864
Collaborator
Sainte-Anne Military Teaching Hospital (Hôpital d'instruction des armées Sainte Anne) (Other)
1,500
3
2.9
500
171

Study Details

Study Description

Brief Summary

Environmental awareness is leading medical field to question its responsibility and possibilities for action.

Drug residues can have a major environmental impact as per their bioaccumulation, toxicity and persistence characteristics, depending on where they are discarded. In France, drug residues should be disposed of by incineration, but in practice this is not systematic. Moreover, data on drug wastage in the operating rooms by anesthesia department are rare.

The GAME-OvBLOC observational study aim to evaluate drug wastage in in the operating rooms by anesthesia department in France and to propose ways of improving health care practices.

Condition or Disease Intervention/Treatment Phase
  • Other: Quantification of intravenous drugs wastage

Detailed Description

Observational study with data collection over a 24-hour business day. Data collected refer to healthcare team's practices and patients.

Study Design

Study Type:
Observational
Anticipated Enrollment :
1500 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Drug Wastage : Observational Study in the Operating Rooms of France
Anticipated Study Start Date :
Feb 1, 2023
Anticipated Primary Completion Date :
May 1, 2023
Anticipated Study Completion Date :
May 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Intravenous (IV) drugs

Patient's data and data relating to prepared/administrated/discarded IV drugs will be collected during 24 hours in the operating rooms by anesthesia department

Other: Quantification of intravenous drugs wastage
Drugs are prescribed at discretion of physicians. For each patient who have anesthesia in the operating room, all labelled syringes having contained drugs (name + dilution) are collected and analyzed.

Outcome Measures

Primary Outcome Measures

  1. Ratio of overall wastage in milliliter (mL) of prepared and discarded IV drugs, to overall volume in milliliter (mL) of prepared IV drugs [24 hours]

    Wastage is defined as : any prepared and unused drug that remains in syringe

Secondary Outcome Measures

  1. Reason for discarding drug residues [24 hours]

    The reason of waste full syringe will be noticed : 1/ prepared in advance and not used ; 2/ prescription change ; 3/ preparation error ; 4/ other reason

  2. Describe drug wastage for each kind of surgery/anesthesia [24 hours]

    Drug wastage according to type of surgery and anaesthesia

  3. Drug residues discarding process [24 hours]

    Questionnaire on nursing practices on the choice of waste disposal circuits according to drugs

  4. Cost of overall IV drugs wastage [24 hours]

    Estimated cost of drug residues will be evaluated for each drug by the following formula : volume of discarded IV drugs x theoretical price

  5. Describe drug wastage for each age group [24 hours]

    Drug wastage according to the following age groups : adult (≥18 years old) and pediatrics (< 1 year old, 1-5 years old, ≥ 6 years old)

  6. Describe waste and environmental impact of used plastic syringes [24 hours]

    Number and volume of used syringes, use of pre-filled syringes, refilling of syringes and multi-patient use. Environmental impact is indirectly assessed by type of plastic used and the transport distance from the production site to France.

  7. Use of alternative to IV drugs [24 hours]

    Alternatives : local anaesthesia and anaesthetic gases

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • All patients who will need an anesthesia act in operating room during a 24 hours period
Exclusion Criteria:
  • Patient opposition to participate in the study or parents opposition if the patient is a child or patient family opposition if the patient is not capable of being informed

Contacts and Locations

Locations

Site City State Country Postal Code
1 University Hospital of Bordeaux, Groupe Sud, Pôle médico-chirurgical Magellan Pessac Gironde France 33600
2 Sainte-Anne Military Teaching Hospital Toulon Var France 83000
3 Centre Hospitalier Intercommunal Toulon - La Seyne sur Mer Toulon Var France 83100

Sponsors and Collaborators

  • Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer
  • Sainte-Anne Military Teaching Hospital (Hôpital d'instruction des armées Sainte Anne)

Investigators

  • Study Director: Erwan D'Aranda, MD, Sainte-Anne Military Teaching Hospital (Hôpital d'instruction des armées Sainte Anne)

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

Responsible Party:
Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer
ClinicalTrials.gov Identifier:
NCT05609864
Other Study ID Numbers:
  • 2023-CHITS-001
First Posted:
Nov 8, 2022
Last Update Posted:
Jan 10, 2023
Last Verified:
Jan 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer

Study Results

No Results Posted as of Jan 10, 2023